Interims show a strong underlying performance with “core established” revenues +11.5% in the period. As previously discussed, the business is in the process of transitioning away from Covid-related work and implementing the growth strategy of the new management team. Initial indications are positive and investment plans are on track, which should set the business up for strong growth in FY23 and beyond. We make no material changes to forecasts and continue to see substantial potential upside on ....

20 Sep 2022
Interims – transition proceeding to plan

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Interims – transition proceeding to plan
EKF Diagnostics Holdings plc (EKF:LON) | 28.0 0 0.0% | Mkt Cap: 127.0m
- Published:
20 Sep 2022 -
Author:
Chris Glasper -
Pages:
3 -
Interims show a strong underlying performance with “core established” revenues +11.5% in the period. As previously discussed, the business is in the process of transitioning away from Covid-related work and implementing the growth strategy of the new management team. Initial indications are positive and investment plans are on track, which should set the business up for strong growth in FY23 and beyond. We make no material changes to forecasts and continue to see substantial potential upside on ....